Metformin therapy can be used as an adjunctive therapy in women undergoing GnRH agonist long protocol, as it may reduce the risk of OHSS and miscarriage (Teede et al. 2023). This evidence concerns the gene GNRH1 and ovarian hyperstimulation syndrome.